According to Chemed's latest financial reports the company's current earnings (TTM) are $0.35 B. an increase over its 2022 earnings that were of $0.33 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | $0.35 B | 5.75% |
2022 | $0.33 B | -5.17% |
2021 | $0.35 B | -11.42% |
2020 | $0.39 B | 49.51% |
2019 | $0.26 B | 8.81% |
2018 | $0.24 B | 101.83% |
2017 | $0.12 B | -32.96% |
2016 | $0.18 B | -1.63% |
2015 | $0.18 B | 7.45% |
2014 | $0.17 B | 22.6% |
2013 | $0.13 B | -12.59% |
2012 | $0.15 B | 3.34% |
2011 | $0.15 B | 5.94% |
2010 | $0.14 B | 10.26% |
2009 | $0.13 B | 3.99% |
2008 | $0.12 B | 3.57% |
2007 | $0.12 B | 13.32% |
2006 | $0.10 B | 36.46% |
2005 | $79.38 M | 32.62% |
2004 | $59.85 M | 812.05% |
2003 | $6.56 M | -64.37% |
2002 | $18.41 M | 4.83% |
2001 | $17.57 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
LHC Group LHCG | $77.2 M | -78.16% | ๐บ๐ธ USA |
Amedisys AMED | $39.62 M | -88.79% | ๐บ๐ธ USA |
Balchem BCPC | $0.15 B | -54.77% | ๐บ๐ธ USA |
Sensient Technologies
SXT | $0.12 B | -63.26% | ๐บ๐ธ USA |